AusCann Group Holdings Ltd
OTC: ACNNF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Christopher Mews B. Bus,
- Employees
- 27
- Headquarters
- West Perth, Australia
- IPO year
- 2017
- Market cap
- $1.7M
- Website
- https://auscann.com.au
Loading ACNNF…
Loading profile data…Frequently asked questions about ACNNF
What does AusCann Group Holdings Ltd (ACNNF) do?
AusCann Group Holdings Ltd currently has no significant operational activities. Historically, the company was dedicated to the research, development, and commercialization of diverse therapeutic products originating from cannabinoids. Its corporate headquarters are located in West Perth, Australia.
Where does ACNNF trade?
AusCann Group Holdings Ltd (ACNNF) trades on the Other OTC.
What sector is ACNNF in?
AusCann Group Holdings Ltd (ACNNF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of AusCann Group Holdings Ltd?
Christopher Mews B. Bus, is the chief executive officer of AusCann Group Holdings Ltd (ACNNF).
Where is AusCann Group Holdings Ltd headquartered?
AusCann Group Holdings Ltd is headquartered in Australia.
Does ACNNF pay a dividend?
AusCann Group Holdings Ltd (ACNNF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ACNNF go public?
AusCann Group Holdings Ltd (ACNNF) completed its initial public offering in 2017.